87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
Simple leukemia treatment change in India cuts early child deaths

Simple leukemia treatment change in India cuts early child deaths

by Mike Addelman,University of ManchesterCredit: Pixabay/CC0 Public DomainA landmark Indian clinical trial has found that giving steroids in short bursts instead of continuously can halve early treatm

Simple leukemia treatment change in India cuts early child deaths

by Mike Addelman,University of ManchesterCredit: Pixabay/CC0 Public DomainA landmark Indian clinical trial has found that giving steroids in short bursts instead of continuously can halve early treatm
Can AI beat breast cancer?

Can AI beat breast cancer?

by David Bradley,InderscienceCredit: Unsplash/CC0 Public DomainAn artificial intelligence (AI) system that combines breast cancer tissue images with molecular marker data achieves high accuracy in dia

Can AI beat breast cancer?

by David Bradley,InderscienceCredit: Unsplash/CC0 Public DomainAn artificial intelligence (AI) system that combines breast cancer tissue images with molecular marker data achieves high accuracy in dia
Experimental drug combination shows early effectiveness in advanced kidney cancer

Experimental drug combination shows early effectiveness in advanced kidney cancer

by Brittany Cordeiro,Mayo ClinicCredit: Unsplash/CC0 Public DomainAn experimental drug combination may help overcome treatment resistance in advanced kidney cancer, according to early results from a f

Experimental drug combination shows early effectiveness in advanced kidney cancer

by Brittany Cordeiro,Mayo ClinicCredit: Unsplash/CC0 Public DomainAn experimental drug combination may help overcome treatment resistance in advanced kidney cancer, according to early results from a f
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer

Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainPreviously, immature overall survival results of the NRG Oncology GY018 (NRG-GY018) trial suggested that the use of the immunotherapy drug pembrolizumab

Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainPreviously, immature overall survival results of the NRG Oncology GY018 (NRG-GY018) trial suggested that the use of the immunotherapy drug pembrolizumab
GLP-1 use linked to lower breast cancer incidence in large cohort study

GLP-1 use linked to lower breast cancer incidence in large cohort study

byPerelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainA retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who

GLP-1 use linked to lower breast cancer incidence in large cohort study

byPerelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainA retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who
Single-cell platform tracks antibody drug delivery inside stubborn solid tumors

Single-cell platform tracks antibody drug delivery inside stubborn solid tumors

byVanderbilt University Medical CenterCredit: Pixabay/CC0 Public DomainArecent paperinNature Biotechnologyexamines problems and solutions for antibody-based therapies for solid pancreatic cancers and

Single-cell platform tracks antibody drug delivery inside stubborn solid tumors

byVanderbilt University Medical CenterCredit: Pixabay/CC0 Public DomainArecent paperinNature Biotechnologyexamines problems and solutions for antibody-based therapies for solid pancreatic cancers and
First‑in‑human study tests gamitrinib designed to disrupt cancer cells' energy systems

First‑in‑human study tests gamitrinib designed to disrupt cancer cells' energy systems

byTemple UniversityAnthony Olszanski, MD, RPh, Vice Chair of Clinical Research in the Department of Hematology/Oncology and Director of the Early Clinical Drug Development Phase 1 Program at Fox Chase

First‑in‑human study tests gamitrinib designed to disrupt cancer cells' energy systems

byTemple UniversityAnthony Olszanski, MD, RPh, Vice Chair of Clinical Research in the Department of Hematology/Oncology and Director of the Early Clinical Drug Development Phase 1 Program at Fox Chase
Cancer vaccine sustains 49% melanoma reduction after 5 years

Cancer vaccine sustains 49% melanoma reduction after 5 years

byNYU Langone HealthCredit: CC0 Public DomainThe combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful in cutting the risk of skin can

Cancer vaccine sustains 49% melanoma reduction after 5 years

byNYU Langone HealthCredit: CC0 Public DomainThe combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful in cutting the risk of skin can
Children's brain tumors may spread faster when microglia build invasion-friendly scaffolding

Children's brain tumors may spread faster when microglia build invasion-friendly scaffolding

by Anna Persson,Karolinska InstitutetCredit: Karolinska InstitutetResearchers at the Institute of Environmental Medicine (IMM), Karolinska Institutet, have identified a possible mechanism behind the s

Children's brain tumors may spread faster when microglia build invasion-friendly scaffolding

by Anna Persson,Karolinska InstitutetCredit: Karolinska InstitutetResearchers at the Institute of Environmental Medicine (IMM), Karolinska Institutet, have identified a possible mechanism behind the s
Why some tumors resist immunotherapy: Blocking miR-25 may help turn 'cold' cancers 'hot'

Why some tumors resist immunotherapy: Blocking miR-25 may help turn 'cold' cancers 'hot'

byUniversity of California - San DiegoCredit: Pixabay/CC0 Public DomainImmune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has transform

Why some tumors resist immunotherapy: Blocking miR-25 may help turn 'cold' cancers 'hot'

byUniversity of California - San DiegoCredit: Pixabay/CC0 Public DomainImmune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has transform
Clinical trial shows tile-based radiation therapy lowers risk of recurrence in brain metastases

Clinical trial shows tile-based radiation therapy lowers risk of recurrence in brain metastases

byUniversity of Texas MD Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that imp

Clinical trial shows tile-based radiation therapy lowers risk of recurrence in brain metastases

byUniversity of Texas MD Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that imp
Study finds 10-plus genetic markers tied to early follicular lymphoma relapse

Study finds 10-plus genetic markers tied to early follicular lymphoma relapse

byUniversity of MissouriFollicular lymphoma (FL) is a type of blood cancer and a form of non-Hodgkin's lymphoma. Thanks to new treatment breakthroughs, about 80% of FL patients have a survival rat

Study finds 10-plus genetic markers tied to early follicular lymphoma relapse

byUniversity of MissouriFollicular lymphoma (FL) is a type of blood cancer and a form of non-Hodgkin's lymphoma. Thanks to new treatment breakthroughs, about 80% of FL patients have a survival rat